Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Construction and Evaluation of a Prognostic Model for Patients with Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 6144.

https://doi.org/10.1182/blood-2024-209459

Published: 2024

Journal Articles

Orelabrutinib Combined with Bendamustine-Rituximab or Obinutuzumab Followed By Orelabrutinib Maintenance Therapy for Untreated Marginal Zone Lymphoma (MZL): A Prospective ,Multicenter, Clinical Study（Optimize Study）

Xuewu Zhang, Yanan Zhu, Xiang Zhang, Xingnong Ye, Gaixiang Xu, Liya Ma, Yanling Ren, Liping Mao, Min Yang, Chunmei Yang, Juying Wei, Yinjun Lou, Wenyuan Mai, Wanzhuo Xie, Haitao Meng, Hongyan Tong, Jie Jin, Wenjuan Yu

Blood (2024) 144 (Supplement 1): 6280.

https://doi.org/10.1182/blood-2024-204442

Published: 2024

Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Blood (2024) 144 (Supplement 1): 836.

https://doi.org/10.1182/blood-2024-208355

Published: 2024

Journal Articles

Practical Application of Orelabrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Analysis of Real-World Evidence (OCARE Study)

Xuewu Zhang, Haitao Meng, Gaixiang Xu, Min Yang, Wanzhuo Xie, Juying Wei, Liya Ma, Xingnong Ye, Liping Mao, Wenyuan Mai, Chunmei Yang, Yanling Ren, Hongyan Tong, Yanan Zhu, Xiang Zhang, Jie Jin, Wenjuan Yu

Blood (2024) 144 (Supplement 1): 6772.

https://doi.org/10.1182/blood-2024-203639

Published: 2024

Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin

Blood (2023) 142 (Supplement 1): 2869.

https://doi.org/10.1182/blood-2023-191190

Published: 2023

Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 6001.

https://doi.org/10.1182/blood-2023-186048

Published: 2023

Journal Articles

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

Jiejing Qian, Jieyu Xu, Qing Hong, Yinjun Lou, Liping Mao, Weilai Xu, Min Yang, Wenjuan Yu, Haitao Meng, Wenyuan Mai, Xiujing Ye, Honghu Zhu, Jie Jin

Blood (2021) 138 (Supplement 1): 4414.

https://doi.org/10.1182/blood-2021-149523

Published: 2021

Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu

Blood (2021) 138 (Supplement 1): 2334.

https://doi.org/10.1182/blood-2021-153257

Published: 2021

Journal Articles

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Blood (2016) 128 (22): 5058.

https://doi.org/10.1182/blood.V128.22.5058.5058

Published: 2016

Journal Articles

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

Wenjuan Yu, MD, Liping Mao, MD, Jiejing Qian, MD, Wenbin Qian, MD, Haitao Meng, MD, Wenyuan Mai, MD, Hongyan Tong, MD, Yin Tong, MD, Jie Jin, MD

Blood (2011) 118 (21): 2595.

https://doi.org/10.1182/blood.V118.21.2595.2595

Published: 2011

Journal Articles

Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.

Hongyan Tong, MD, PhD, Yanling Ren, MD, Feng Xiao, MD, Wenyuan Mai, MD, PhD, Haitao Meng, MD, PhD, Wenbin Qian, MD, PhD, Jie Jin, MD, PhD

Blood (2007) 110 (11): 3576.

https://doi.org/10.1182/blood.V110.11.3576.3576

Published: 2007

Journal Articles

Retrospective Study on T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding and Survival.

Hongyan Tong, MD, PhD, Feng Xiao, MD, Tieying Dai, MD, Jie Jin, MD,PhD, Haitao Meng, MD,PhD, Wenbing Qian, MD,PhD, Wenyuan Mai, MD,PhD, Fengjuan Zhang, MD, Hui Liu, MD

Blood (2006) 108 (11): 4652.

https://doi.org/10.1182/blood.V108.11.4652.4652

Published: 2006

Journal Articles

Prevention of Homoharringtonine Induced Apoptosis by Antioxidants in K562 Cells.

Wenyuan Mai, MD, PhD, Maofang Lin, MD

Blood (2006) 108 (11): 4378.

https://doi.org/10.1182/blood.V108.11.4378.4378

Published: 2006

Journal Articles

Homoharringtonine Based Triple-Drug Regimen as Induction Chemotherapy for De Novo Acute Myelogenous Leukemia.

Jie Jin, Wenbin Qian, Hui Liu, Daozi Jian, Wenyuan Mai, Hongyan Tong, Haitao Men

Blood (2006) 108 (11): 2002.

https://doi.org/10.1182/blood.V108.11.2002.2002

Published: 2006

Journal Articles

Effect of Homoharringtonine on Differentiation and Apoptosis of Human Leukemic Cell.

Wenyuan Mai, MD, PhD, Maofang Lin, MD

Blood (2005) 106 (11): 4425.

https://doi.org/10.1182/blood.V106.11.4425.4425

Published: 2005

NARROW

Construction and Evaluation of a Prognostic Model for Patients with Acute Myeloid Leukemia

Orelabrutinib Combined with Bendamustine-Rituximab or Obinutuzumab Followed By Orelabrutinib Maintenance Therapy for Untreated Marginal Zone Lymphoma (MZL): A Prospective ,Multicenter, Clinical Study（Optimize Study）

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: A Prospective, Multicenter, Phase 2 Trial

Practical Application of Orelabrutinib in Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Analysis of Real-World Evidence (OCARE Study)

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

A Real World Study of Venetoclax Combined with Azacitidine in 64 Chinese Patients Newly Diagnosed Acute Myeloid Leukemia

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Prognostic Significance of IDH1 and IDH2 mutations in Older Patients with Primary Cytogenetically Normal Acute Myeloid Leukemia

Homoharringtonine in Combination with Cytarabine and Aclarubicin in the Treatment of Refractory/Relapsed Acute Myeloid Leukemia: a Single-Center Experience

Clinical Characteristics of T-Cell Lymphoma Associated Hemophagocytic Syndrome: Comparison of T-Cell Lymphoma with and without Hemophagocytic Syndrome.

Retrospective Study on T Cell Malignent Lymphoma: Classification, Manifestation, Laboratory Finding and Survival.

Prevention of Homoharringtonine Induced Apoptosis by Antioxidants in K562 Cells.

Homoharringtonine Based Triple-Drug Regimen as Induction Chemotherapy for De Novo Acute Myelogenous Leukemia.

Effect of Homoharringtonine on Differentiation and Apoptosis of Human Leukemic Cell.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only